Correction
This article was originally published in The Tan Sheet
Executive Summary
In an item on p. 10 of the Feb. 15 issue of "The Tan Sheet," incorrect figures were reported for two of Sanofi-Aventis' statements. The firm said it plans to double its subsidiary Chattem's annual sales of $463 million, and Sanofi paid $1.9 billion for Chattem in the deal that closed in February. We regret the errors